Oorsprong van het eerstegraads netwerk van Marc E. Uknis
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 26 | |
| Extinct | Biotechnology | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Marc E. Uknis via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
JMP Securities LLC
 JMP Securities LLC Investment Banks/BrokersFinance Citizens JMP Securities LLC (Citizens JMP) is a full-service investment bank and broker/dealer headquartered in San Francisco, California. The firm was founded by Joseph Jolson in 2002 and was formerly JMP Securities LLC. The firm is a subsidiary of JMP Holding LLC, ultimately held by Citizens Financial Group, Inc. (NYSE: CFG). Citizens JMP provides equity research, institutional brokerage, and investment banking services to public and private growth companies and their investors. They are a research-driven, growth-oriented firm that provides services to small- and mid-sized companies and the institutions that invest in them. The firm specializes in four high-growth sectors of the economy: technology, healthcare, financial services, and real estate. | Investment Banks/Brokers | Corporate Officer/Principal | |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Founder Chief Executive Officer General Counsel Chief Operating Officer Comptroller/Controller/Auditor | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman General Counsel | |
| University of Notre Dame | College/University | Undergraduate Degree | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| Emory University | College/University | Graduate Degree | |
| ZOETIS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| St. Joseph's University | College/University | Masters Business Admin Masters Business Admin | |
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
Cardiac Rhythm Management
 Cardiac Rhythm Management Medical SpecialtiesHealth Technology Part of Japan Lifeline Co., Ltd., Cardiac Rhythm Management is a company that manufactures implantable devices to treat arrhythmias. The company is based in Sylmar, CA. | Medical Specialties | Corporate Officer/Principal | |
Illinois Biotechnology Industry Organization
 Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives. | Miscellaneous Commercial Services | Director/Board Member | |
| Philadelphia College of Osteopathic Medicine | College/University | Corporate Officer/Principal | |
| Sanofi-Aventis Pharmaceuticals | Corporate Officer/Principal | ||
Hawthorne Race Course, Inc.
 Hawthorne Race Course, Inc. Casinos/GamingConsumer Services Hawthorne Race Course, Inc. owns and operates a horseracing track in Stickney, Illinois. The one mile horse track features harness, quarter horse, and thoroughbred racing. The company was founded in 1891 and is headquartered in Cicero, IL. | Casinos/Gaming | Director/Board Member | |
The Heart Care Group
 The Heart Care Group Medical/Nursing ServicesHealth Services The Heart Care Group is an outpatient cardiac care practice that prioritizes wellbeing and preventative care. The American company offers a new take on cardiac wellness. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| UNIQURE N.V. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Beyond Air Ltd.
 Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | Biotechnology | Director/Board Member | |
Red Hen Corp.
 Red Hen Corp. RestaurantsConsumer Services Red Hen Corp. operates a bar. The private company is based in Chicago, IL. | Restaurants | Director/Board Member | |
| Suburban Downs, Inc. | Director/Board Member | ||
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
IEcure, Inc.
 IEcure, Inc. BiotechnologyHealth Technology iECURE, Inc. is a gene editing company that focuses on developing therapies for liver disorders with significant unmet need. The company is based in Plymouth Meeting, PA, and the CEO of the company is Joseph Truitt. The company's approach involves mutation-agnostic in vivo gene insertion or knock-in editing, which has the potential to replace and restore the function of a dysfunctional gene, regardless of mutation. iECURE collaborates with the University of Pennsylvania's Gene Therapy Program to utilize their translational expertise and infrastructure. The company's management team has extensive experience in executing orphan drug and gene therapy clinical trials and successfully commercializing multiple products. iECURE's programs are currently focused on developing in vivo gene insertion therapies for the treatment of rare pediatric liver diseases. | Biotechnology | Chief Executive Officer Director/Board Member Chief Operating Officer | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
| Hershey Medical Center | College/University | Corporate Officer/Principal | |
| CADRENAL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
DiNAQOR AG
 DiNAQOR AG BiotechnologyHealth Technology DiNAQOR AG is a Swiss genetic medicine platform company that focuses on developing innovative solutions for patients with severe, inherited forms of heart disease. The private company is based in Pfäffikon, Switzerland, and has additional presence in Massachusetts and other locations. The company's lead preclinical program, DINA-001, is aimed at treating mybpc3-linked cardiomyopathy. Founded in 2019, the CEO of DiNAQOR is Johannes Holzmeister. | Biotechnology | Director/Board Member | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Beyond Cancer, Ltd.
 Beyond Cancer, Ltd. BiotechnologyHealth Technology Beyond Cancer, Ltd. is a development-stage biopharmaceutical and Bermudian medical device company that utilizes a proprietary delivery platform to treat primary tumors and prevent metastatic disease. The private company is based in Hamilton, Bermuda. Beyond Cancer is currently conducting a first-in-human study in patients with solid tumors and is focused on next level immuno-oncology. The CEO of the company is Selena A. Chaisson. | Biotechnology | Director/Board Member | |
| ACELYRIN, INC. | Pharmaceuticals: Major | Founder |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Verenigd Koninkrijk | 3 |
| Ierland | 2 |
| Duitsland | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 195 |
| Corporate Officer/Principal | 80 |
| Independent Dir/Board Member | 52 |
| Chief Executive Officer | 29 |
| President | 29 |
Sterkste connecties
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Jason S. Fisherman | 30 |
| Nicole Vitullo | 29 |
| Robert Carey | 23 |
| Robert van Nostrand | 22 |
| David I. Scheer | 19 |
| David Lubner | 19 |
| Frank Verwiel | 16 |
| Kurt Graves | 15 |
| Tu Yen Ong | 13 |
| Steven Zelenkofske | 13 |
| Brian DiDonato | 13 |
| Martha Manning | 13 |
| Anthony Gibney | 11 |
| Milind Deshpande | 11 |
- Beurs
- Insiders
- Marc E. Uknis
- Bedrijfsconnecties
